Cytochrome P450 Structure, Function and Clinical Significance: A Review

被引:619
作者
Manikandan, Palrasu [1 ]
Nagini, Siddavaram [2 ]
机构
[1] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA
[2] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India
关键词
Adverse drug reactions (ADRs); cytochrome P450; drug interactions; genetic polymorphisms; microRNA; moon-lighting proteins; xenobiotics; PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; ARYL-HYDROCARBON RECEPTOR; HUMAN LIVER-MICROSOMES; DRUG-DRUG INTERACTIONS; IN-VITRO; GENE-EXPRESSION; DNA METHYLATION; CROSS-TALK; EPIGENETIC REGULATION;
D O I
10.2174/1389450118666170125144557
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The cytochrome P450 (CYP) enzymes are membrane-bound hemoproteins that play a pivotal role in the detoxification of xenobiotics, cellular metabolism and homeostasis. Induction or inhibition of CYP enzymes is a major mechanism that underlies drug-drug interactions. CYP enzymes can be transcriptionally activated by various xenobiotics and endogenous substrates through receptor-dependent mechanisms. CYP enzyme inhibition is a principal mechanism for metabolism-based drug-drug interactions. Many chemotherapeutic drugs can cause drug interactions due to their ability to either inhibit or induce the CYP enzyme system. Predictions based on in silico analyses followed by validation have identified several microRNAs that regulate CYPs. Genetic polymorphisms and epigenetic changes in CYP genes may be responsible for inter-individual and interethnic variations in disease susceptibility and the therapeutic efficacy of drugs. Objective: The present review is a comprehensive compilation of cytochrome P450 structure, function, pharmacogenetics, pharmacoepigenetics and clinical significance. Conclusion: Knowledge about the substrates, inducers, and inhibitors of CYP isoforms, as well as the polymorphisms of CYP enzymes may be used as an aid by clinicians to determine therapeutic strategy, and treatment doses for drugs that are metabolized by CYP gene products.
引用
收藏
页码:38 / 54
页数:17
相关论文
共 185 条
[1]   Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain [J].
Al-Anizy, M ;
Horley, NJ ;
Kuo, CWS ;
Gillett, LC ;
Laughton, CA ;
Kendall, D ;
Barrett, DA ;
Parker, T ;
Bell, DR .
FEBS JOURNAL, 2006, 273 (05) :936-947
[2]   A map of human genome variation from population-scale sequencing [J].
Altshuler, David ;
Durbin, Richard M. ;
Abecasis, Goncalo R. ;
Bentley, David R. ;
Chakravarti, Aravinda ;
Clark, Andrew G. ;
Collins, Francis S. ;
De la Vega, Francisco M. ;
Donnelly, Peter ;
Egholm, Michael ;
Flicek, Paul ;
Gabriel, Stacey B. ;
Gibbs, Richard A. ;
Knoppers, Bartha M. ;
Lander, Eric S. ;
Lehrach, Hans ;
Mardis, Elaine R. ;
McVean, Gil A. ;
Nickerson, DebbieA. ;
Peltonen, Leena ;
Schafer, Alan J. ;
Sherry, Stephen T. ;
Wang, Jun ;
Wilson, Richard K. ;
Gibbs, Richard A. ;
Deiros, David ;
Metzker, Mike ;
Muzny, Donna ;
Reid, Jeff ;
Wheeler, David ;
Wang, Jun ;
Li, Jingxiang ;
Jian, Min ;
Li, Guoqing ;
Li, Ruiqiang ;
Liang, Huiqing ;
Tian, Geng ;
Wang, Bo ;
Wang, Jian ;
Wang, Wei ;
Yang, Huanming ;
Zhang, Xiuqing ;
Zheng, Huisong ;
Lander, Eric S. ;
Altshuler, David L. ;
Ambrogio, Lauren ;
Bloom, Toby ;
Cibulskis, Kristian ;
Fennell, Tim J. ;
Gabriel, Stacey B. .
NATURE, 2010, 467 (7319) :1061-1073
[3]   Integrating common and rare genetic variation in diverse human populations [J].
Altshuler, David M. ;
Gibbs, Richard A. ;
Peltonen, Leena ;
Dermitzakis, Emmanouil ;
Schaffner, Stephen F. ;
Yu, Fuli ;
Bonnen, Penelope E. ;
de Bakker, Paul I. W. ;
Deloukas, Panos ;
Gabriel, Stacey B. ;
Gwilliam, Rhian ;
Hunt, Sarah ;
Inouye, Michael ;
Jia, Xiaoming ;
Palotie, Aarno ;
Parkin, Melissa ;
Whittaker, Pamela ;
Chang, Kyle ;
Hawes, Alicia ;
Lewis, Lora R. ;
Ren, Yanru ;
Wheeler, David ;
Muzny, Donna Marie ;
Barnes, Chris ;
Darvishi, Katayoon ;
Hurles, Matthew ;
Korn, Joshua M. ;
Kristiansson, Kati ;
Lee, Charles ;
McCarroll, Steven A. ;
Nemesh, James ;
Keinan, Alon ;
Montgomery, Stephen B. ;
Pollack, Samuela ;
Price, Alkes L. ;
Soranzo, Nicole ;
Gonzaga-Jauregui, Claudia ;
Anttila, Verneri ;
Brodeur, Wendy ;
Daly, Mark J. ;
Leslie, Stephen ;
McVean, Gil ;
Moutsianas, Loukas ;
Nguyen, Huy ;
Zhang, Qingrun ;
Ghori, Mohammed J. R. ;
McGinnis, Ralph ;
McLaren, William ;
Takeuchi, Fumihiko ;
Grossman, Sharon R. .
NATURE, 2010, 467 (7311) :52-58
[4]   Interactions between antiretrovirals and antineoplastic drug therapy [J].
Antoniou, T ;
Tseng, AL .
CLINICAL PHARMACOKINETICS, 2005, 44 (02) :111-145
[5]  
Anttila S, 2003, CANCER RES, V63, P8623
[6]   Artemisinin and CYP2A6 activity in healthy subjects [J].
Asimus, Sara ;
Hai, Trinh Ngoc ;
Huong, Nguyen Van ;
Ashton, Michael .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (03) :283-292
[7]   Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[8]   Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions [J].
Backman, Janne T. ;
Filppula, Anne M. ;
Niemi, Mikko ;
Neuvonen, Pertti J. .
PHARMACOLOGICAL REVIEWS, 2016, 68 (01) :168-241
[9]   Role of Epigenetic Mechanisms in Differential Regulation of the Dioxin-Inducible Human CYP1A1 and CYP1B1 Genes [J].
Beedanagari, Sudheer R. ;
Taylor, Robert T. ;
Bui, Peter ;
Wang, Feng ;
Nickerson, Derek W. ;
Hankinson, Oliver .
MOLECULAR PHARMACOLOGY, 2010, 78 (04) :608-616
[10]   Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213